• 1
    Dong, C. and Flavell, R. A., Cell fate decision: T-helper 1 and 2 subsets in immune responses. Arthritis Res. 2000. 2: 179188.
  • 2
    Hultgren, B., Huang, X., Dybdal, N. and Stewart, T. A., Genetic absence of gamma-interferon delays but does not prevent diabetes in NOD mice. Diabetes 1996. 45: 812817.
  • 3
    Serreze, D. V., Post, C. M., Chapman, H. D., Johnson, E. A., Lu, B. and Rothman, P. B., Interferon-gamma receptor signaling is dispensable in the development of autoimmune type 1 diabetes in NOD mice. Diabetes 2000. 49: 20072011.
  • 4
    Trembleau, S., Penna, G., Gregori, S., Chapman, H. D., Serreze, D. V., Magram, J. and Adorini, L., Pancreas-infiltrating Th1 cells and diabetes develop in IL-12-deficient nonobese diabetic mice. J. Immunol. 1999. 163: 29602968.
  • 5
    Katz, J. D., Benoist, C. and Mathis, D., T helper cell subsets in insulin-dependent diabetes. Science 1995. 268: 11851188.
  • 6
    Wang, B., Andre, I., Gonzalez, A., Katz, J. D., Aguet, M., Benoist, C. and Mathis, D., Interferon-gamma impacts at multiple points during the progression of autoimmune diabetes. Proc. Natl. Acad. Sci. USA 1997. 94: 1384413849.
  • 7
    Bettelli, E., Oukka, M. and Kuchroo, V. K., T(H)-17 cells in the circle of immunity and autoimmunity. Nat. Immunol. 2007. 8: 345350.
  • 8
    Dong, C., TH17 cells in development: an updated view of their molecular identity and genetic programming. Nat. Rev. Immunol. 2008. 8: 337348.
  • 9
    Dong, G., Ye, R., Shi, W., Liu, S., Wang, T., Yang, X., Yang, N. and Yu, X., IL-17 induces autoantibody overproduction and peripheral blood mononuclear cell overexpression of IL-6 in lupus nephritis patients. Chin. Med. J. (Engl.) 2003. 116: 543548.
  • 10
    Langrish, C. L., Chen, Y., Blumenschein, W. M., Mattson, J., Basham, B., Sedgwick, J. D., McClanahan, T. et al., IL-23 drives a pathogenic T cell population that induces autoimmune inflammation. J. Exp. Med. 2005. 201: 233240.
  • 11
    Murphy, C. A., Langrish, C. L., Chen, Y., Blumenschein, W., McClanahan, T., Kastelein, R. A., Sedgwick, J. D. and Cua, D. J., Divergent pro- and antiinflammatory roles for IL-23 and IL-12 in joint autoimmune inflammation. J. Exp. Med. 2003. 198: 19511957.
  • 12
    Park, H., Li, Z., Yang, X. O., Chang, S. H., Nurieva, R., Wang, Y. H., Wang, Y. et al., A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17. Nat. Immunol. 2005. 6: 11331141.
  • 13
    Jain, R., Tartar, D. M., Gregg, R. K., Divekar, R. D., Bell, J. J., Lee, H. H., Yu, P. et al., Innocuous IFNgamma induced by adjuvant-free antigen restores normoglycemia in NOD mice through inhibition of IL-17 production. J. Exp. Med. 2008. 205: 207218.
  • 14
    Stark, M. A., Huo, Y., Burcin, T. L., Morris, M. A., Olson, T. S. and Ley, K., Phagocytosis of apoptotic neutrophils regulates granulopoiesis via IL-23 and IL-17. Immunity 2005. 22: 285294.
  • 15
    Judkowski, V., Pinilla, C., Schroder, K., Tucker, L., Sarvetnick, N. and Wilson, D. B., Identification of MHC class II-restricted peptide ligands, including a glutamic acid decarboxylase 65 sequence, that stimulate diabetogenic T cells from transgenic BDC2.5 nonobese diabetic mice. J. Immunol. 2001. 166: 908917.
  • 16
    Nurieva, R., Yang, X. O., Martinez, G., Zhang, Y., Panopoulos, A. D., Ma, L., Schluns, K. et al., Essential autocrine regulation by IL-21 in the generation of inflammatory T cells. Nature 2007. 448: 480483.
  • 17
    Pakala, S. V., Kurrer, M. O. and Katz, J. D., T helper 2 (Th2) T cells induce acute pancreatitis and diabetes in immune-compromised nonobese diabetic (NOD) mice. J. Exp. Med. 1997. 186: 299306.
  • 18
    Katz, J. D., Wang, B., Haskins, K., Benoist, C. and Mathis, D., Following a diabetogenic T cell from genesis through pathogenesis. Cell 1993. 74: 10891100.
  • 19
    Gonzalez, A., Andre-Schmutz, I., Carnaud, C., Mathis, D. and Benoist, C., Damage control, rather than unresponsiveness, effected by protective DX5+ T cells in autoimmune diabetes. Nat. Immunol. 2001. 2: 11171125.
  • 20
    Sarvetnick, N., Shizuru, J., Liggitt, D., Martin, L., McIntyre, B., Gregory, A., Parslow, T. and Stewart, T., Loss of pancreatic islet tolerance induced by beta-cell expression of interferon-gamma. Nature 1990. 346: 844847.
  • 21
    Serreze, D. V., Chapman, H. D., Post, C. M., Johnson, E. A., Suarez-Pinzon, W. L. and Rabinovitch, A., Th1 to Th2 cytokine shifts in nonobese diabetic mice: sometimes an outcome, rather than the cause, of diabetes resistance elicited by immunostimulation. J. Immunol. 2001. 166: 13521359.
  • 22
    Matos, M., Park, R., Mathis, D. and Benoist, C., Progression to islet destruction in a cyclophosphamide-induced transgenic model: a microarray overview. Diabetes 2004. 53: 23102321.
  • 23
    Muranski, P., Boni, A., Antony, P. A., Cassard, L., Irvine, K. R., Kaiser, A., Paulos, C. M. et al., Tumor-specific Th17-polarized cells eradicate large established melanoma. Blood 2008. 112: 362373.
  • 24
    Yang, X. O., Chang, S. H., Park, H., Nurieva, R., Shah, B., Acero, L., Wang, Y.-H. et al., Regulation of inflammatory responses by IL-17F. J. Exp. Med. 2008. 205: 10631075.